Larvol Delta - Arcturus-Therapeutics-Receives-Orphan-Drug-Designation-from-the-US-FDA-for-ARCT032-for-the-Treatment-of-Cystic-Fibrosis

ARCT-032 - Arcturus Therap

https://www.businesswire.com/news/home/20231127768908/en/Arcturus-Therapeutics-Receives-Orphan-Drug-Designation-from-the-U.S.-FDA-for-ARCT-032-for-the-Treatment-of-Cystic-Fibrosis

Nov 27, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next